+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genu Recurvatum Market: Global Opportunity Analysis and Industry Forecast, 2024-2033- Product Image
Genu Recurvatum Market: Global Opportunity Analysis and Industry Forecast, 2024-2033- Product Image
Sale

Genu Recurvatum Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 216 Pages
  • October 2024
  • Region: Global
  • Allied Market Research
  • ID: 6053896
UP TO OFF until Jun 30th 2025
Description Jump to:
The genu recurvatum market was valued at $6.5 billion in 2023, and is projected to reach $11.2 billion by 2033, growing at a CAGR of 5.6% from 2024 to 2033.

Genu recurvatum is a medical condition characterized by hyperextension of the knee joint, leading to an abnormal backward curvature while standing or walking. This condition can be caused by a variety of factors, including congenital anomalies, neuromuscular disorders, ligamentous laxity, or trauma. Genu recurvatum can range from mild to severe and often affects joint stability, gait mechanics, and overall mobility. Depending on its severity and underlying cause, it may be associated with discomfort, a higher risk of knee injuries, or long-term joint degeneration if left untreated.

The global genu recurvatum market is witnessing robust growth due to factors such as alarming rise in prevalence of neuromuscular disorders such as cerebral palsy, muscular dystrophy, and post-stroke complications, which increase the incidence of genu recurvatum, and surge in demand for therapeutic and corrective solutions. A 2022 study published by National Institutes of Health (NIH) - one of the world's foremost medical research centers - revealed that on an average the prevalence of individuals who inherited neuromuscular disorders is 3.7-4.99 per 10,000. In addition, rise in awareness of knee-related deformities and their long-term impact on mobility and quality of life has boosted early diagnosis and treatment adoption.

Furthermore, increase in incidence of knee injuries due to sports, accidents, and other trauma has propelled the demand for rehabilitative therapies, including solutions for secondary conditions like genu recurvatum. Moreover, surge in geriatric population acts as the key driving force of the global market. This is attributed to the fact that older adults are more susceptible to joint laxity and degenerative conditions, increasing the need for both conservative and surgical interventions for genu recurvatum. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030.

Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. However, lack of awareness and delayed diagnosis significantly restrains the market growth. Genu recurvatum often remains underdiagnosed, especially in milder cases or in underserved regions, due to a lack of awareness among patients and healthcare providers.

Furthermore, high cost associated with surgical procedures, custom orthotics, and advanced rehabilitation technologies hampers the market growth. On the contrary, innovations in knee braces, prosthetics, and assistive devices tailored to manage genu recurvatum have expanded treatment options, improving patient outcomes. Such developments are expected to open new avenues for the expansion of the global market during the forecast period.

The global genu recurvatum market is segmented into treatment type, end user, and region. On the basis of treatment type, the market is categorized into human surgical treatments and non-surgical treatments. Further, the surgical treatments segment is divided into osteotomy, arthroscopy, and knee realignment surgeries. The non-surgical treatments segment is subsegmented into physical therapy, bracing & orthotics, and rehabilitation exercises. Depending on end user, it is categorized into hospitals, orthopedic clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By treatment type, the non-surgical treatments segment is expected to dominate the market from 2024 to 2033.

On the basis of end user, orthopedic clinics segment is anticipated to exhibit the highest growth during the forecast period.

Region wise, the genu recurvatum market is likely to witness strong growth in North America.

Competition Analysis

Competitive analysis and profiles of the major players in the global genu recurvatum market include Medtronic Plc, Stryker Corporation, Smith & Nephew Plc, Johnson and Johnson (DePuy Synthes), Zimmer Biomet Holdings, Inc., Globus Medical Inc, Össur, aspen medical products, and Thuasne Group, Breg, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update* (with the purchase of an enterprise license)
  • 5 additional Company Profiles, pre- or post-purchase, as a free update.
  • Free Updated Version (once released) with the purchase of an enterprise user license.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Expanded list for Company Profiles
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Treatment Type

  • Surgical Treatments
  • Osteotomy
  • Arthroscopy
  • Knee Realignment Surgeries
  • Non-Surgical Treatments
  • Physical Therapy
  • Bracing and Orthotics
  • Rehabilitation Exercises

By End User

  • Hospitals
  • Orthopedic Clinics
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • medtronic PLc
  • Stryker Corporation
  • Smith & Nephew plc
  • Johnson and Johnson (DePuy Synthes)
  • Zimmer Biomet Holdings, Inc.
  • Globus Medical Inc
  • Össur
  • aspen medical products
  • Thuasne Group
  • Breg, Inc

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: GENU RECURVATUM MARKET, BY TREATMENT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Treatment Type
4.2. Surgical Treatments
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.2.5. Osteotomy
4.2.5.1. Market Size and Forecast
4.2.6. Arthroscopy
4.2.6.1. Market Size and Forecast
4.2.7. Knee Realignment Surgeries
4.2.7.1. Market Size and Forecast
4.3. Non-Surgical Treatments
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.3.5. Physical Therapy
4.3.5.1. Market Size and Forecast
4.3.6. Bracing and Orthotics
4.3.6.1. Market Size and Forecast
4.3.7. Rehabilitation Exercises
4.3.7.1. Market Size and Forecast
CHAPTER 5: GENU RECURVATUM MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Orthopedic Clinics
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: GENU RECURVATUM MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Treatment Type
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Genu Recurvatum Market
6.2.5.1. Market Size and Forecast, By Treatment Type
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Genu Recurvatum Market
6.2.6.1. Market Size and Forecast, By Treatment Type
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Genu Recurvatum Market
6.2.7.1. Market Size and Forecast, By Treatment Type
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Treatment Type
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. France Genu Recurvatum Market
6.3.5.1. Market Size and Forecast, By Treatment Type
6.3.5.2. Market Size and Forecast, By End User
6.3.6. Germany Genu Recurvatum Market
6.3.6.1. Market Size and Forecast, By Treatment Type
6.3.6.2. Market Size and Forecast, By End User
6.3.7. Italy Genu Recurvatum Market
6.3.7.1. Market Size and Forecast, By Treatment Type
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Spain Genu Recurvatum Market
6.3.8.1. Market Size and Forecast, By Treatment Type
6.3.8.2. Market Size and Forecast, By End User
6.3.9. UK Genu Recurvatum Market
6.3.9.1. Market Size and Forecast, By Treatment Type
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest Of Europe Genu Recurvatum Market
6.3.10.1. Market Size and Forecast, By Treatment Type
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Treatment Type
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. China Genu Recurvatum Market
6.4.5.1. Market Size and Forecast, By Treatment Type
6.4.5.2. Market Size and Forecast, By End User
6.4.6. Japan Genu Recurvatum Market
6.4.6.1. Market Size and Forecast, By Treatment Type
6.4.6.2. Market Size and Forecast, By End User
6.4.7. India Genu Recurvatum Market
6.4.7.1. Market Size and Forecast, By Treatment Type
6.4.7.2. Market Size and Forecast, By End User
6.4.8. South Korea Genu Recurvatum Market
6.4.8.1. Market Size and Forecast, By Treatment Type
6.4.8.2. Market Size and Forecast, By End User
6.4.9. Australia Genu Recurvatum Market
6.4.9.1. Market Size and Forecast, By Treatment Type
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Genu Recurvatum Market
6.4.10.1. Market Size and Forecast, By Treatment Type
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Treatment Type
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Genu Recurvatum Market
6.5.5.1. Market Size and Forecast, By Treatment Type
6.5.5.2. Market Size and Forecast, By End User
6.5.6. South Africa Genu Recurvatum Market
6.5.6.1. Market Size and Forecast, By Treatment Type
6.5.6.2. Market Size and Forecast, By End User
6.5.7. Saudi Arabia Genu Recurvatum Market
6.5.7.1. Market Size and Forecast, By Treatment Type
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Genu Recurvatum Market
6.5.8.1. Market Size and Forecast, By Treatment Type
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Medtronic PLc
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Stryker Corporation
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Smith And Nephew Plc
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Johnson And Johnson (DePuy Synthes)
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Zimmer Biomet Holdings, Inc.
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Globus Medical Inc
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Össur
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Aspen Medical Products
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Thuasne Group
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Breg, Inc
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 2. Genu Recurvatum Market for Surgical Treatments, by Region, 2024 - 2033 ($Billion)
Table 3. Genu Recurvatum Market for Non-Surgical Treatments, by Region, 2024 - 2033 ($Billion)
Table 4. Global Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 5. Genu Recurvatum Market for Hospitals, by Region, 2024 - 2033 ($Billion)
Table 6. Genu Recurvatum Market for Orthopedic Clinics, by Region, 2024 - 2033 ($Billion)
Table 7. Genu Recurvatum Market for Others, by Region, 2024 - 2033 ($Billion)
Table 8. Genu Recurvatum Market, by Region, 2024 - 2033 ($Billion)
Table 9. North America Genu Recurvatum Market, by Country, 2024 - 2033 ($Billion)
Table 10. North America Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 11. North America Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 12. U.S. Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 13. U.S. Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 14. Canada Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 15. Canada Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 16. Mexico Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 17. Mexico Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 18. Europe Genu Recurvatum Market, by Country, 2024 - 2033 ($Billion)
Table 19. Europe Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 20. Europe Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 21. France Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 22. France Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 23. Germany Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 24. Germany Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 25. Italy Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 26. Italy Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 27. Spain Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 28. Spain Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 29. UK Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 30. UK Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 31. Rest of Europe Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 32. Rest of Europe Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 33. Asia-Pacific Genu Recurvatum Market, by Country, 2024 - 2033 ($Billion)
Table 34. Asia-Pacific Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 35. Asia-Pacific Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 36. China Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 37. China Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 38. Japan Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 39. Japan Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 40. India Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 41. India Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 42. South Korea Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 43. South Korea Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 44. Australia Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 45. Australia Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 46. Rest of Asia-Pacific Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 47. Rest of Asia-Pacific Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 48. LAMEA Genu Recurvatum Market, by Country, 2024 - 2033 ($Billion)
Table 49. LAMEA Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 50. LAMEA Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 51. Brazil Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 52. Brazil Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 53. South Africa Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 54. South Africa Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 55. Saudi Arabia Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 56. Saudi Arabia Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 57. Rest of LAMEA Genu Recurvatum Market, by Treatment Type, 2024 - 2033 ($Billion)
Table 58. Rest of LAMEA Genu Recurvatum Market, by End-user, 2024 - 2033 ($Billion)
Table 59. Medtronic PLC: Key Executives
Table 60. Medtronic PLC: Company Snapshot
Table 61. Medtronic PLC: Operating Segments
Table 62. Medtronic PLC: Product Portfolio
Table 63. Medtronic PLC: Key Strategic Moves and Developments
Table 64. Stryker Corporation: Key Executives
Table 65. Stryker Corporation: Company Snapshot
Table 66. Stryker Corporation: Operating Segments
Table 67. Stryker Corporation: Product Portfolio
Table 68. Stryker Corporation: Key Strategic Moves and Developments
Table 69. Smith and Nephew PLC: Key Executives
Table 70. Smith and Nephew PLC: Company Snapshot
Table 71. Smith and Nephew PLC: Operating Segments
Table 72. Smith and Nephew PLC: Product Portfolio
Table 73. Smith and Nephew PLC: Key Strategic Moves and Developments
Table 74. Johnson and Johnson (Depuy Synthes) : Key Executives
Table 75. Johnson and Johnson (Depuy Synthes) : Company Snapshot
Table 76. Johnson and Johnson (Depuy Synthes) : Operating Segments
Table 77. Johnson and Johnson (Depuy Synthes) : Product Portfolio
Table 78. Johnson and Johnson (Depuy Synthes) : Key Strategic Moves and Developments
Table 79. Zimmer Biomet Holdings, Inc.: Key Executives
Table 80. Zimmer Biomet Holdings, Inc.: Company Snapshot
Table 81. Zimmer Biomet Holdings, Inc.: Operating Segments
Table 82. Zimmer Biomet Holdings, Inc.: Product Portfolio
Table 83. Zimmer Biomet Holdings, Inc.: Key Strategic Moves and Developments
Table 84. Globus Medical Inc.: Key Executives
Table 85. Globus Medical Inc.: Company Snapshot
Table 86. Globus Medical Inc.: Operating Segments
Table 87. Globus Medical Inc.: Product Portfolio
Table 88. Globus Medical Inc.: Key Strategic Moves and Developments
Table 89. Össur: Key Executives
Table 90. Össur: Company Snapshot
Table 91. Össur: Operating Segments
Table 92. Össur: Product Portfolio
Table 93. Össur: Key Strategic Moves and Developments
Table 94. Aspen Medical Products: Key Executives
Table 95. Aspen Medical Products: Company Snapshot
Table 96. Aspen Medical Products: Operating Segments
Table 97. Aspen Medical Products: Product Portfolio
Table 98. Aspen Medical Products: Key Strategic Moves and Developments
Table 99. Thuasne Group: Key Executives
Table 100. Thuasne Group: Company Snapshot
Table 101. Thuasne Group: Operating Segments
Table 102. Thuasne Group: Product Portfolio
Table 103. Thuasne Group: Key Strategic Moves and Developments
Table 104. Breg, Inc.: Key Executives
Table 105. Breg, Inc.: Company Snapshot
Table 106. Breg, Inc.: Operating Segments
Table 107. Breg, Inc.: Product Portfolio
Table 108. Breg, Inc.: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Genu Recurvatum Market, 2024 - 2033
Figure 2. Segmentation of Genu Recurvatum Market, 2024 - 2033
Figure 3. Top Investment Pocket in Genu Recurvatum Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalgenu Recurvatum Market
Figure 10. Global Genu Recurvatum Market Segmentation, by Treatment Type
Figure 11. Genu Recurvatum Market for Surgical Treatments, by Country, 2024 - 2033 ($Billion)
Figure 12. Genu Recurvatum Market for Non-Surgical Treatments, by Country, 2024 - 2033 ($Billion)
Figure 13. Global Genu Recurvatum Market Segmentation, by End-user
Figure 14. Genu Recurvatum Market for Hospitals, by Country, 2024 - 2033 ($Billion)
Figure 15. Genu Recurvatum Market for Orthopedic Clinics, by Country, 2024 - 2033 ($Billion)
Figure 16. Genu Recurvatum Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 17. Top Winning Strategies, by Year, 2021-2023*
Figure 18. Top Winning Strategies, by Development, 2021-2023*
Figure 19. Top Winning Strategies, by Company, 2021-2023*
Figure 20. Product Mapping of Top 10 Players
Figure 21. Competitive Dashboard
Figure 22. Competitive Heatmap: Genu Recurvatum Market
Figure 23. Top Player Positioning, 2023
Figure 24. Medtronic PLC: Net Sales, 2021-2023 ($Billion)
Figure 25. Medtronic PLC: Revenue Share, by Segment, 2023 (%)
Figure 26. Medtronic PLC: Revenue Share, by Region, 2023 (%)
Figure 27. Stryker Corporation: Net Sales, 2021-2023 ($Billion)
Figure 28. Stryker Corporation: Revenue Share, by Segment, 2023 (%)
Figure 29. Stryker Corporation: Revenue Share, by Region, 2023 (%)
Figure 30. Smith and Nephew PLC: Net Sales, 2021-2023 ($Billion)
Figure 31. Smith and Nephew PLC: Revenue Share, by Segment, 2023 (%)
Figure 32. Smith and Nephew PLC: Revenue Share, by Region, 2023 (%)
Figure 33. Johnson and Johnson (Depuy Synthes) : Net Sales, 2021-2023 ($Billion)
Figure 34. Johnson and Johnson (Depuy Synthes) : Revenue Share, by Segment, 2023 (%)
Figure 35. Johnson and Johnson (Depuy Synthes) : Revenue Share, by Region, 2023 (%)
Figure 36. Zimmer Biomet Holdings, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 37. Zimmer Biomet Holdings, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 38. Zimmer Biomet Holdings, Inc.: Revenue Share, by Region, 2023 (%)
Figure 39. Globus Medical Inc.: Net Sales, 2021-2023 ($Billion)
Figure 40. Globus Medical Inc.: Revenue Share, by Segment, 2023 (%)
Figure 41. Globus Medical Inc.: Revenue Share, by Region, 2023 (%)
Figure 42. Össur: Net Sales, 2021-2023 ($Billion)
Figure 43. Össur: Revenue Share, by Segment, 2023 (%)
Figure 44. Össur: Revenue Share, by Region, 2023 (%)
Figure 45. Aspen Medical Products: Net Sales, 2021-2023 ($Billion)
Figure 46. Aspen Medical Products: Revenue Share, by Segment, 2023 (%)
Figure 47. Aspen Medical Products: Revenue Share, by Region, 2023 (%)
Figure 48. Thuasne Group: Net Sales, 2021-2023 ($Billion)
Figure 49. Thuasne Group: Revenue Share, by Segment, 2023 (%)
Figure 50. Thuasne Group: Revenue Share, by Region, 2023 (%)
Figure 51. Breg, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 52. Breg, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 53. Breg, Inc.: Revenue Share, by Region, 2023 (%)

Companies Mentioned

  • medtronic PLc
  • Stryker Corporation
  • Smith & Nephew plc
  • Johnson and Johnson (DePuy Synthes)
  • Zimmer Biomet Holdings, Inc.
  • Globus Medical Inc
  • Össur
  • aspen medical products
  • Thuasne Group
  • Breg, Inc

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages216
PublishedOctober 2024
Forecast Period2023 - 2033
Estimated Market Value ( USD ) in 2023 $ 6.5 billion
Forecasted Market Value ( USD ) by 2033 $ 11.2 billion
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Genu Recurvatum Market Report 2025 - Product Image

Genu Recurvatum Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Genu Recurvatum Market Size, Share & Trends Analysis Report By Treatment Type, By End User (Hospitals, Orthopedic Clinics, and Other End User), By Regional Outlook and Forecast, 2024 - 2031 - Product Image

Genu Recurvatum Market Size, Share & Trends Analysis Report By Treatment Type, By End User (Hospitals, Orthopedic Clinics, and Other End User), By Regional Outlook and Forecast, 2024 - 2031

  • Report
  • 242 Pages
  • Global
From
Sports Medicine Market 2025-2033 - Product Image

Sports Medicine Market 2025-2033

  • Report
  • 146 Pages
  • Global
From
Sports Medicine Market 2024-2028 - Product Image

Sports Medicine Market 2024-2028

  • Report
  • 164 Pages
  • Global
From
Sports Medicine Market Global Report by Product, Application, End-User, Countries and Company Analysis 2025-2033 - Product Image

Sports Medicine Market Global Report by Product, Application, End-User, Countries and Company Analysis 2025-2033

  • Report
  • 215 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.